Skip to content

Cellulose sulfate microbicide safe and acceptable to HIV-positive women

Genetic testing can predict who is at risk of abacavir hypersensitivity

Patients taking three-drug NRTI therapy should switch, even if they have durable virological suppression

Uganda: criminal probe recommended in AIDS fund scam

Conflicting pharmacokinetic results when lopinavir and atazanavir are double-boosted with ritonavir

Final declaration of commitment on HIV/AIDS adopted — disagreement over strengths and weaknesses persist

Four more Ranbaxy drugs on WHO pre-qualification list

Three million years of life saved by AIDS care in the United States

Serious heart condition still more common in HIV-positive people despite antiretrovirals